Activation of hepatocyte growth factor by urokinase-type plasminogen activator is ionic strength-dependent

Por Mars, Wendy M., Jo, Minji, Gonias, Steven L.
Publicado em 2005

The Urokinase Receptor Promotes Cancer Metastasis Independently of Urokinase-Type Plasminogen Activator in Mice

Por Jo, Minji, Takimoto, Shinako, Montel, Valerie, Gonias, Steven L.
Publicado em 2009

Low Density Lipoprotein Receptor-related Protein (LRP1) Regulates Rac1 and RhoA Reciprocally to Control Schwann Cell Adhesion and Migration

Por Mantuano, Elisabetta, Jo, Minji, Gonias, Steven L., Campana, W. Marie
Publicado em 2010

uPAR induces epithelial–mesenchymal transition in hypoxic breast cancer cells

Por Lester, Robin D., Jo, Minji, Montel, Valérie, Takimoto, Shinako, Gonias, Steven L.
Publicado em 2007

A Transformation in the Mechanism by which the Urokinase Receptor Signals Provides a Selection Advantage for Estrogen Receptor-expressing Breast Cancer Cells in the Absence of Estr...

Por Eastman, Boryana M., Jo, Minji, Webb, Drue L., Takimoto, Shinako, Gonias, Steven L.
Publicado em 2012

Reversibility of Epithelial-Mesenchymal Transition (EMT) Induced in Breast Cancer Cells by Activation of Urokinase Receptor-dependent Cell Signaling

Por Jo, Minji, Lester, Robin D., Montel, Valerie, Eastman, Boryana, Takimoto, Shinako, Gonias, Steven L.
Publicado em 2009

Dynamic Phosphorylation of Tyrosine 665 in Pseudopodium-enriched Atypical Kinase 1 (PEAK1) Is Essential for the Regulation of Cell Migration and Focal Adhesion Turnover

Por Bristow, Jeanne M., Reno, Theresa A., Jo, Minji, Gonias, Steven L., Klemke, Richard L.
Publicado em 2013

Cell Signaling by Urokinase-type Plasminogen Activator Receptor Induces Stem Cell–like Properties in Breast Cancer Cells

Por Jo, Minji, Eastman, Boryana M., Webb, Drue L., Stoletov, Konstantin, Klemke, Richard, Gonias, Steven L.
Publicado em 2010

uPAR Induces Expression of Transforming Growth Factor β and Interleukin-4 in Cancer Cells to Promote Tumor-Permissive Conditioning of Macrophages

Por Hu, Jingjing, Jo, Minji, Eastman, Boryana M., Gilder, Andrew S., Bui, Jack D., Gonias, Steven L.
Publicado no Am J Pathol (2014)

Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells

Por Hu, Jingjing, Jo, Minji, Cavenee, Webster K., Furnari, Frank, VandenBerg, Scott R., Gonias, Steven L.
Publicado em 2011

Precise tuning of the glyoxylate cycle in Escherichia coli for efficient tyrosine production from acetate

Por Jo, Minji, Noh, Myung Hyun, Lim, Hyun Gyu, Kang, Chae Won, Im, Dae-Kyun, Oh, Min-Kyu, Jung, Gyoo Yeol
Publicado no Microb Cell Fact (2019)

Myeloid Cell Receptor LRP1/CD91 Regulates Monocyte Recruitment and Angiogenesis in Tumors

Por Staudt, Nicole D., Jo, Minji, Hu, Jingjing, Bristow, Jeanne M., Pizzo, Donald P., Gaultier, Alban, VandenBerg, Scott R., Gonias, Steven L.
Publicado em 2013

Mechanisms of palmitic acid-conjugated antisense oligonucleotide distribution in mice

Por Chappell, Alfred E, Gaus, Hans J, Berdeja, Andres, Gupta, Ruchi, Jo, Minji, Prakash, Thazha P, Oestergaard, Michael, Swayze, Eric E, Seth, Punit P
Publicado no Nucleic Acids Res (2020)

Utility of Squaraine Dyes for Dye-Sensitized Photocatalysis on Water or Carbon Dioxide Reduction

Por Jo, Minji, Choi, Sunghan, Jo, Ju Hyoung, Kim, So-Yoen, Kim, Pil Soo, Kim, Chul Hoon, Son, Ho-Jin, Pac, Chyongjin, Kang, Sang Ook
Publicado no ACS Omega (2019)

Enhanced Potency of GalNAc-Conjugated Antisense Oligonucleotides in Hepatocellular Cancer Models

Por Kim, Youngsoo, Jo, Minji, Schmidt, Joanna, Luo, Xiaolin, Prakash, Thazha P., Zhou, Tianyuan, Klein, Stephanie, Xiao, Xiaokun, Post, Noah, Yin, Zhengfeng, MacLeod, A. Robert
Publicado no Mol Ther (2019)

Partial Hepatectomy Induced Long Noncoding RNA Inhibits Hepatocyte Proliferation during Liver Regeneration

Por Huang, Lulu, Damle, Sagar S., Booten, Sheri, Singh, Priyam, Sabripour, Mahyar, Hsu, Jeff, Jo, Minji, Katz, Melanie, Watt, Andy, Hart, Christopher E., Freier, Susan M., Monia, Brett P., Guo, Shuling
Publicado no PLoS One (2015)

AZD9150, a Next-Generation Antisense Oligonucleotide Inhibitor of STAT3 with Early Evidence of Clinical Activity in Lymphoma and Lung Cancer

Por Hong, David, Kurzrock, Razelle, Kim, Youngsoo, Woessner, Richard, Younes, Anas, Nemunaitis, John, Fowler, Nathan, Zhou, Tianyuan, Schmidt, Joanna, Jo, Minji, Lee, Samantha J., Yamashita, Mason, Hughes, Steven G., Fayad, Luis, Piha-Paul, Sarina, Nadella, Murali VP, Mohseni, Morvarid, Lawson, Deborah, Reimer, Corinne, Blakey, David C., Xiao, Xiaokun, Hsu, Jeff, Revenko, Alexey, Monia, Brett P., MacLeod, A. Robert
Publicado no Sci Transl Med (2015)

STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial.

Por Reilley, Matthew J., McCoon, Patricia, Cook, Carl, Lyne, Paul, Kurzrock, Razelle, Kim, Youngsoo, Woessner, Richard, Younes, Anas, Nemunaitis, John, Fowler, Nathan, Curran, Michael, Liu, Qinying, Zhou, Tianyuan, Schmidt, Joanna, Jo, Minji, Lee, Samantha J., Yamashita, Mason, Hughes, Steven G., Fayad, Luis, Piha-Paul, Sarina, Nadella, Murali V. P., Xiao, Xiaokun, Hsu, Jeff, Revenko, Alexey, Monia, Brett P., MacLeod, A. Robert, Hong, David S.
Publicado no J Immunother Cancer (2018)